Targeting notch1 with berbamine alleviates the inflammatory responses of macrophages in sepsis
- 8 June 2025
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 161, 115033
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82370408)
- Natural Science Foundation of Shanghai Municipality (24ZR1429500)
- Shanghai Municipal Health Commission (2022YQ064)
This publication has 35 references indexed in Scilit:
- Interaction, diagnosis, and treatment of lung microbiota-NLRP3 inflammasome-target organ axis in sepsisInternational Immunopharmacology, 2025
- Berbamine prevents SARS-CoV-2 entry and transmissioniScience, 2024
- Demethylzeylasteral induces PD-L1 ubiquitin–proteasome degradation and promotes antitumor immunity via targeting USP22Acta Pharmaceutica Sinica B, 2024
- Berbamine ameliorates DSS-induced colitis by inhibiting peptidyl-arginine deiminase 4-dependent neutrophil extracellular traps formationEuropean Journal of Pharmacology, 2024
- Targeting Notch1-YAP Circuit Reprograms Macrophage Polarization and Alleviates Acute Liver Injury in MiceCellular and Molecular Gastroenterology and Hepatology, 2023
- Review: the Role and Mechanisms of Macrophage Autophagy in SepsisInflammation, 2018
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Berberine: New perspectives for old remediesBiochemical Pharmacology, 2012
- Notch Signaling in the Immune SystemImmunity, 2010
- Integrated Regulation of Toll-like Receptor Responses by Notch and Interferon-γ PathwaysImmunity, 2008